Riskpilot← Back to searchSign inGet full accessAPOTEK SPITSBERGEN AS
ASActiveOrg 992153040Lompensentret Vei 5028, 9170 LongyearbyenRetail sale of pharmaceutical products · NACE 4773Est. 20082 employees
Revenue 2024
NOK 12,6M
+11% vs 2023
EBITDA margin
13.5%
+21% vs 2023
Equity ratio
74.6%
Financial strength
Net profit 2024
NOK 1,4M
+29% vs 2023
| Revenue | NOK 12,6M | +11% |
| EBITDA | NOK 1,7M | +21% |
| Net profit | NOK 1,4M | +29% |
| Total assets | NOK 7M | +13% |
| Equity | NOK 5,2M | +19% |
| Employees | 2 | — |
Legal name
APOTEK SPITSBERGEN AS
Org number
992153040
Legal form
Aksjeselskap
NACE code
4773 · Retail sale of pharmaceutical products
Founded
9. januar 2008
Share capital
NOK 100 000
Employees
2 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Butikkhandel med apotekvarer og helseartikler samt salg av farmasøyttjenster.
Address
Lompensentret Vei 5028, 9170 Longyearbyen
Phone
+4779021212
Email
apotek.spitsbergen@apotek1.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 9 328 | 10 026 | 11 136 | 11 415 | 12 629 |
| Staff expenses | −1 617 | −1 846 | −1 732 | −2 245 | −2 178 |
| EBITDA | 1 279 | 1 132 | 2 019 | 1 408 | 1 710 |
| Depreciation & amort. | −95 | −75 | −72 | −51 | −10 |
| EBIT | 1 183 | 1 058 | 1 947 | 1 357 | 1 701 |
| Net financials | −30 | −27 | −28 | −34 | 4 |
| Profit before tax | 1 154 | 1 031 | 1 919 | 1 323 | 1 705 |
| Tax | 189 | 168 | 311 | 216 | 273 |
| Net profit | 965 | 863 | 1 608 | 1 107 | 1 431 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 5 453 | 5 720 | 5 427 | 6 233 | 7 030 |
| Equity | 2 831 | 2 295 | 3 303 | 4 410 | 5 241 |
| Long-term debt | 670 | 550 | 430 | 1 | 1 |
| Short-term debt | 1 952 | 2 875 | 1 695 | 1 822 | 1 788 |
| Total debt | 2 622 | 3 425 | 2 125 | 1 823 | 1 789 |
EBITDA margin
13.5%
This company
15.8%
Market median
-15% vs market
20202024
Equity ratio
74.6%
This company
38.2%
Market median
+95% vs market
20202024
Return on equity
27.3%
This company
18.4%
Market median
+48% vs market
20202024
Net profit margin
11.3%
This company
8.1%
Market median
+40% vs market
20202024
Asset turnover
1.80×
This company
1.12×
Market median
+61% vs market
20202024
Debt / equity
0.34×
This company
0.62×
Market median
+45% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
BY Chief Executive Officer | Chief Executive Officer | 2015 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2014 | |
| Board of Directors | 2014 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of APOTEK SPITSBERGEN AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Borghild Yttredal | Chief Executive Officer | 0 companies |
| Berit Fossland | Chairman | 0 companies |
| Tone Helen Hauge | Board of Directors | 0 companies |